![[feed]](/style/images/feed-icon-14x14.png){kind=icon}
Tools
Tools
Preview |
PDF (Original Article)
- Requires a PDF viewer such as GSview, Xpdf or Adobe Acrobat Reader
3MB |
| Item Type: | Article |
|---|---|
| Title: | Cardiac phase-resolved T(2)* magnetic resonance imaging reveals differences between normal hearts and a humanized mouse model of hypertrophic cardiomyopathy |
| Creators Name: | Laghzali, O., Shalikar, S., Liu, S., Lehmann, S., dos Santos Periquito, J., Pohlmann, A., Waiczies, S., Carrier, L., Yang, H.J., Niendorf, T. and Ku, M.C. |
| Abstract: | BACKGROUND/OBJECTIVES: While T(2)* mapping effectively assesses cerebral blood oxygenation, its utility for capturing cardiac phase-dependent myocardial changes in hypertrophic cardiomyopathy (HCM) is underexplored. This study investigates T(2)* dynamics in an HCM mouse model, to validate T(2)* as a clinically relevant biomarker for improved HCM diagnosis and treatment monitoring. METHODS: A cardiac-specific Mybpc3 genetic mouse model, closely mirroring human HCM, was used with 12 young mice (6–11 weeks old), including both male and female wild-type (WT) and Mybpc3-KI (HCM) groups. The cardiac function was assessed using self-gated multi-slice 2D CINE imaging. To investigate myocardial T(2)* variations across the cardiac cycle, multi-gradient echo (MGE) imaging was employed. This approach used retrospective gating and continuous acquisition synchronization with pulse oximetry at 9.4 T small animal MRI. RESULTS: Mybpc3-KI mice demonstrated left-ventricular (LV) hypertrophy compared to WT (HCM = 50.08 ± 4.68 µm/g vs. WT = 45.80 ± 20.07 µm/g, p < 0.01) and reduced ejection fraction (HCM = 38.55 ± 5.39% vs. WT= 72.53 ± 3.95%, p < 0.01). Myocardial T(2)* was significantly elevated in HCM across all cardiac phases (HCM = 12.14 ± 1.54 ms vs. WT = 7.93 ± 1.57 ms, p = 0.002). Strong correlations were observed between myocardial T(2)* and LV mass (rho = 0.88, p = 0.03). CONCLUSIONS: T(2)* was elevated in HCM with increased LV mass, highlighting the potential of T(2)* MRI as a sensitive biomarker for distinguishing healthy mice from those with HCM and revealing possible myocardial abnormalities. |
| Keywords: | Hypertrophic Cardiomyopathy (HCM), Myocardial Tissue Characterization, Cardiac MRI, Parametric Imaging, T(2)* Mapping |
| Source: | Biomedicines |
| ISSN: | 2227-9059 |
| Publisher: | MDPI |
| Volume: | 13 |
| Number: | 5 |
| Page Range: | 1193 |
| Date: | May 2025 |
| Official Publication: | https://doi.org/10.3390/biomedicines13051193 |
Repository Staff Only: item control page
